Week 1 2021
Ilana Solomon, ScM, MA, CGC
Cancer Risk Counselor
Ilana Solomon, ScM, MA, CGC is a board-certified licensed genetic counselor focusing in cancer risk assessment. She graduated from the Johns Hopkins/ National Human Genome Research Institute Genetic Counseling Training Program in January 2013. Previously trained as an anthropologist, she also holds a masters degree in physical anthropology from New York University and a bachelors degree in anthropology from Binghamton University. Ilana joined the City of Hope Division of Clinical Cancer Genomics in 2013. Her past research focuses on the psychosocial impact of receiving Variants of Unknown Significance (VUS). She currently specializes in hereditary gastrointestinal syndromes focusing on hereditary gastric cancer. Ilana also has interests in genomics education and genetic counseling research including patient-centered care, risk communication and the concept of uncertainty in healthcare. She is an active member of the National Society of Genetic Counselors (NSGC) and is Co-Chair for the Research sub-committee of the NSGC Cancer Special Interest Group.
Susan Shehayeb, MS, CGC
Cancer Risk Counselor
Susan Shehayeb, MS, CGC, is a licensed board-certified genetic counselor specializing in cancer genetics. She has a Master’s of Science degree in genetic counseling from University of California Irvine. Previous to completing her master’s degree, Ms. Shehayeb earned her bachelor’s degree in molecular, cell and developmental biology from University of California Los Angeles. Ms. Shehayeb joined the City of Hope Division of Clinical Cancer Genomics in 2017, having previously undergone clinical training at City of Hope. She is fluent in Arabic and is in the process of achieving fluency in Spanish. She has participated in the training of genetic counseling students from multiple programs, including assuming the role of rotation supervisor. Ms. Shehayeb's clinical role has centered on widening patient access to genetic counseling and testing throughout the City of Hope network as the lead genetic counselor for the City of Hope | South Pasadena site. Her past research investigated lifestyle choices in the context of genetic counseling and genetic testing for cancer risk. She is a member of the National Society of Genetic Counselors and the Southern California Genetic Counselors.
Jeffrey Weitzel, MD
Professor of Oncology and Population Sciences
Jeffrey N. Weitzel, MD is Founder of the Division of Clinical Cancer Genomics and the Cancer Screening & Prevention Program at City of Hope Comprehensive Cancer Center in Duarte, California. Board Certified in Clinical Genetics and Medical Oncology, Dr. Weitzel is a Professor of Oncology and Population Sciences at City of Hope, and holder of the Dr. Norman and Melinda Payson Professorship in Medical Oncology. He is also the ASCO Conquer Cancer Research Professor in Breast Cancer Disparities. At the vanguard of precision prevention, Dr. Weitzel’s multidisciplinary clinical, research, and training programs emphasize translational research in cancer disparities, genomic cancer risk assessment, chemoprevention, targeted therapy, clinical and psychosocial outcomes, genetic epidemiology and health services research, with a focus on underserved populations. He is member of the NCCN Genetics/Familial Risk Assessment practice guidelines committee. Dr. Weitzel is the principal investigator for the Clinical Cancer Genomics Community Research Network and Medical Director for the Cancer Genomics Education Program, which are funded in part by the National Cancer Institute. Along with Dr. Blazer, he received the 2019 American Society of Human Genetics Arno Motulsky-Barton Childs Award for Excellence in Human Genetics Education.